Make your voice heard. Learn about 340B legislation at the state level and federal reform efforts in Washington.

Prohibitions Against Discriminatory Practices Related to 340B Entities and Drugs

HB 1281
Read the Bill

• 1/8/26 – Introduced
• 1/13/26 – First Reading
• 1/15/26 – Referred to Health Care Facilities & Systems Subcommittee, Insurance & Banking Subcommittee, and Health & Human Services Committee

SB 1638
Read the Bill

• 1/9/26 – Filed
• 1/16/26 – Referred to Banking & Insurance; Health Policy; Rules
• 1/22/26 – Introduced

Requires an audit of the 340B program in Illinois.

Read the Bill

• 1/7/26 – Introduced
• 1/14/26 – Referred to Rules Committee
• 2/11/26 – Assigned to Executive Committee

Regulation of 340B Drug Manufacturers and Distributors

HF 2009
Read the Bill

• 1/13/26 – Introduced + Referred to Health and Human Services
• 1/14/26 – Assigned to Subcommittee
• 1/21/26 – Subcommittee recommends passage

Prohibiting Discrimination Against 340B Drug Entities

H.785
Read the Bill

• 3/31/25 – Referred to Financial Services
• 6/3/25 – Joint Hearing
• 9/18/25 – Reported Favorably + Referred to Health Care Financing
• 12/8/25 – Reporting date extended to 3/8/26

H.1296
Read the Bill

• 6/3/25 – Joint Hearing

H.4495
Read the Bill

• 9/18/25 – Reported from Financial Services + Referred to Health Care Financing
• 12/8/25 – Reporting date extended to 3/8/26

S.779
Read the Bill

• 6/3/25 – Joint Hearing
• 12/4/25 – Senate Study Order

Prohibitions Against Discriminatory Practices Related to 340B Entities and Drugs

HB 4878
Read the Bill

• 9/11/25 – Introduced and referred to Committee on Health Policy
• 1/28/26 – Reported with recommendation for referral to Committee on Rules
• 1/28/26 – Recommendation concurred

SB 94
Read the Bill

• 2/20/25 – Introduced and referred to Committee on Oversight
• 2/26/25 – Reported Favorably Without Amendment & Referred to Committee of the Whole
• 3/5/25 – Reported Favorably Without Amendment
• 3/6/25 – PASSED Senate 33-3
• 3/6/25 – Received by House and Referred to Committee on Health Policy

Prescription Drugs Delivery Restrictions Prohibition

SF 3769

• 02/23/26 – Introduction and first reading
• 02/23/26 – Referred to Commerce and Consumer Protection

Disallowance of drug manufacturers from restricting delivery of 340B prescription drugs continued, enforcement provided, and expiration date removed

HF 3609

• 02/23/26 – Introduction and first reading
• 02/23/26 – Referred to Health and Finance Policy

Missouri 340B Drug Pricing Program Reporting

HB 2081
Read the Bill

• 12/1/25 – Prefiled
• 1/7/26 – Read First Time
• 1/8/26 – Read Second Time

SB 1213
Read the Bill

• 12/1/25 – Prefiled
• 1/7/26 – Read First Time
• 1/27/26 – Second Read and Referred S Families, Seniors, and Health Committee
• 2/4/26 – Hearing conducted S Families, Seniors, and Health Committee

SB 1178 
Read the Bill

• 12/1/25 – Prefiled
• 1/7/26 – Read First Time
• 1/27/26 – Second Read and Referred S Families, Seniors, and Health Committee
• 2/4/26 – Hearing conducted S Families, Seniors, and Health Committee

Prohibiting Discrimination Against 340B Drug Entities by Insurers and PBMs

SB 1340
Read the Bill

• 12/1/25 – Prefiled
• 1/7/26 – Read First Time
• 1/27/26 – Second Read and Referred S Families, Seniors, and Health Committee

SB 846
Read the Bill

• 12/1/25 – Prefiled
• 1/7/26 – Read First Time
• 1/8/26 – Referred to Insurance and Banking Committee

Increasing Transparency in the 340B Drug Pricing Program

HB 1755
Read the Bill

• 1/7/26 – Introduced and Referred to Health, Human Services and Elderly Affairs Committee
• 1/21/26 – Public Hearing – 11:30AM
• 1/28/26 – Refer to Interim Study
• 2/12/26 – Motion adopted Voice Vote

SB 477
Read the Bill

• 1/7/26 – Introduced and Referred to Health and Human Services Committee
• 1/21/26 – Hearing – 1:30PM
• 2/12/26 – Committee Report – Referred to Interim Study
• 2/19/26 – Vote 5-0; Consent Calendar; Senate Calendar 6
• 2/19/26 – Removed from Consent Calendar; Senate Journal 4
• 2/19/26 – Special Order to the Next Session, Without Objection, Motion Adopted – Senate Journal 4
• 2/19/26 – Referred to Interim Study, 3/5/26, Vote 5-0; Senate Calendar 8

340B Prescription Drug Anti-Discrimination Act

A6222
Read the Bill

• 1/7/26 – Referred to Health

S1913
Read the Bill

• 1/7/26 – Referred to Health
• 1/27/26 – Reported and committed to Finance

Prohibiting Restrictions on Contract Pharmacies

SB 278
Read the Bill

• 1/13/26 – Introduced and Referred to Committee on Education and Health
• 1/20/26 – Assigned to Subcommittee on Health
• 1/29/26 – Reported from Education and Health Committee with substitute; referred to Finance and Appropriations Committee
• 2/11/26 – Reported from Finance and Appropriations with substitute
• 2/12/26 – Rules suspended
• 2/12/26 – Constitutional reading dispensed Block Vote (on 1st reading)
• 2/12/26 – Passed by for the day Block Vote (Voice Vote)
• 2/13/26 – Committee substitute printed 26107756D-S2
• 2/13/26 – Read second time
• 2/13/26 – Committee substitute rejected (Voice Vote)
• 2/13/26 – Committee substitute agreed to (Voice Vote)
• 2/13/26 – Engrossed by Senate – committee substitute (Voice Vote)
• 2/16/26 – Read third time and passed Senate
• 2/19/26 – Placed on Calendar
• 2/19/26 – Read first time
• 2/19/26 – Referred to Committee on Health and Human Services
• 2/23/26 – Assigned sub: Health
• 2/23/26 – Fiscal Impact Statement from Department of Planning and Budget (SB278)
• 2/24/26 – House subcommittee offered

Protecting Patient Access to Discounted Medications via 340B Program

SB 5981
Read the Bill

• 1/5/26 – Prefiled
• 1/12/26 – Read First Time + Referred to Health & Long Term Care
• 1/16/26 – Hearing: 8AM
• 1/27/26 – Recommended do pass
• 1/28/26 – Referred to Ways & Means
• 2/5/26 – Public hearing in the Senate Committee on Ways & Means at 1:30 PM.
• 2/9/26 – Executive action taken in the Senate Committee on Ways & Means at 10:30 AM.
• 2/9/26 – WM – Majority; 2nd substitute bill be substituted, do pass.
• 2/9/26 – Minority; do not pass.
• 2/9/26 – Minority; without recommendation.
• 2/9/26 – Passed to Rules Committee for second reading.
• 2/10/26 – Placed on second reading by Rules Committee.
• 2/13/26 – 2nd substitute bill substituted
• 2/13/26 – Floor Amendments Adopted
• 2/13/26 – Rules suspended. Placed on Third Reading.
• 2/13/26 – Third reading, passed; yeas, 30; nays, 18; absent, 0; excused, 1
• 2/17/26 – First reading, referred to Health Care & Wellness.
• 2/20/26 – Public hearing in the House Committee on Health Care & Wellness at 8:00 AM.
• 2/25/26 – Executive action taken in the House Committee on Health Care & Wellness at 1:30 PM.
• 2/25/26 – HCW – Majority; do pass with amendment(s)
• 2/25/26 – Minority; do not pass.
• 2/25/26 – Minority; without recommendation.
• 2/25/26 – Referred to Appropriations.

HB 2145
Read the Bill

• 12/15/25 – Prefiled
• 1/12/26 – Read First Time + Referred to Health Care & Wellness
• 1/23/26 – Recommended do pass
• 1/28/26 – Referred to Appropriations
• 2/6/26 – Public hearing in the House Committee on Appropriations at 10:30 AM
• 2/9/26 – Executive action taken in the House Committee on Appropriations at 10:30 AM.
• 2/9/26 – APP – Majority; 2nd substitute bill be substituted, do pass
• 2/9/26 – Minority; do not pass.
• 2/9/26 – Minority; without recommendation.
• 2/9/26 – Referred to Rules 2 Review.